The FDA approval of Otulfi™, Fresenius Kabi’s fourth biosimilar product in the U.S. market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. and ...

Spanish healthcare data analysis firm Sequentia Biotech has secured €10m in funding to drive its software designed to advance ...

In this free webinar, learn about the science behind omega 3, 9 and 11 fatty acids and their impact on metabolic processes and the adipose tissue. Attendees will gain insights into key evidence on the ...

Animal feed additives manufacturer Anpario revealed on Monday that it had acquired US animal health and nutrition products business Bio-Vet.

At some supermarkets, plant-based “meat” products are getting more shelf space or even an entire section of a fridge, unlike ...

The aquaculture nutrition market in Japan is projected to grow at a 5.5% CAGR from 2024 to 2034, fueled by consumer demand ...

Created by former Monsanto communications director Jay Byrne, the private Bonus Eventus platform provides its members with a ...

Worldwide dietary changes are partly due to consumers questioning the traditional production and consumption of animal-based ...

A study conducted by researchers from the Kwame Nkrumah University of Science and Technology (KNUST) has revealed alarming ...

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Fresenius Kabi, in partnership with Formycon AG, has received European Commission approval for Otulfi®, a biosimilar of ...

Heart Healthy Diet is critical in maintaining cardiovascular health, revealing the impact of sodium, plant-based alternatives ...